XML 52 R41.htm IDEA: XBRL DOCUMENT v3.25.3

Note 16 - Share-based Payments (Tables)

9 Months Ended

Sep. 30, 2025

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

		Three Months Ended September 30, 2025								Three Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,046,219			$	39.82				1,186,961			$	54.30
Granted			23,000				17.38				146,408				22.02
Exercised			-				-				-				-
Forfeited			(2,760	)			24.55				(19,402	)			33.78
Expired			(114,988	)			50.35				(123,507	)			54.87
Outstanding, end of period			951,471				37.63				1,190,460				45.71
Options exercisable, end of period			535,018			$	52.34				625,627			$	59.02

		Nine Months Ended September 30, 2025								Nine Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			1,122,700			$	45.86				1,132,632			$	54.61
Granted			129,814				18.94				323,358				21.02
Exercised			-				-				-				-
Forfeited			(48,528	)			29.53				(92,374	)			24.73
Expired			(252,515	)			56.65				(173,156	)			56.33
Outstanding, end of period			951,471				37.63				1,190,460				45.71
Options exercisable, end of period			535,018			$	52.34				625,627			$	59.02

		Three Months Ended September 30, 2025								Three Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			15,626,013			$	1.33				16,779,846			$	1.30
Granted			264,250				1.81				341,500				1.78
Exercised			-				-				-				-
Forfeited			(58,742	)			1.55				(864,167	)			1.28
Expired			(171,695	)			1.31				(154,701	)			1.27
Outstanding, end of period			15,659,826				1.34				16,102,478				1.31
Options exercisable, end of period			13,032,265			$	1.28				9,602,704			$	1.27

		Nine Months Ended September 30, 2025								Nine Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			15,887,997			$	1.27				16,333,233			$	1.27
Granted			653,250				1.79				1,261,000				1.75
Exercised			(24,420	)			1.27				-				-
Forfeited			(264,923	)			1.53				(1,166,121	)			1.29
Expired			(592,078	)			1.30				(325,634	)			1.27
Outstanding, end of period			15,659,826				1.34				16,102,478				1.31
Options exercisable, end of period			13,032,265			$	1.28				9,602,704			$	1.27

		Three Months Ended September 30, 2025								Three Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			4,717,769			$	6.00				6,969,256			$	6.00
Granted			-				-				-				-
Exercised			-				-				-				-
Forfeited			(7,095	)			6.00				(350,269	)			6.00
Expired			-				-				-				-
Outstanding, end of period			4,710,674				6.00				6,618,987				6.00
Options exercisable, end of period			4,141,928			$	6.00				4,200,364			$	6.00

		Nine Months Ended September 30, 2025								Nine Months Ended September 30, 2024
		Number of shares				Weighted average exercise price per share				Number of shares				Weighted average exercise price per share
Outstanding, beginning of period			5,959,660			$	6.00				7,504,269			$	6.00
Granted			-				-				123,000				6.00
Exercised			-				-				-				-
Forfeited			(98,753	)			6.00				(798,249	)			6.00
Expired			(1,150,233	)			6.00				(210,033	)			6.00
Outstanding, end of period			4,710,674				6.00				6,618,987				6.00
Options exercisable, end of period			4,141,928			$	6.00				4,200,364			$	6.00

Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$16.47 - $19.93			147,162			$	2.62				0.6			$	36				19,375			$	19.20				4.4			$	8
$20.25 - $28.37			357,230				22.79				5.5				-				116,692				23.53				5.3				-
$30.70 - $30.74			5,000				30.74				4.2				-				2,500				30.74				4.2				-
$40.04 - $48.00			129,340				42.00				3.7				-				96,108				42.02				3.7				-
$51.82 - $59.98			13,350				55.53				1.3				-				13,350				55.53				1.3				-
$60.01 - $68.41			146,066				60.93				1.2				-				144,896				60.94				1.2				-
$70.13 - $79.51			144,323				78.48				2.1				-				135,347				78.70				2.2				-
$80.61 - $82.07			9,000				80.61				3.0				-				6,750				80.61				3.0				-
			951,471			$	37.63				3.2			$	36				535,018			$	52.34				3.0			$	8

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $1.81			15,659,826			$	1.34				4.1			$	7,434				13,032,265			$	1.28				4.1			$	6,866
			15,659,826			$	1.34				4.1			$	7,434				13,032,265			$	1.28				4.1			$	6,866

		Options outstanding																Options exercisable
Exercise price		Number outstanding				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value				Number exercisable				Weighted average exercise price per share				Weighted average remaining contractual life (years)				Aggregate intrinsic value
$0 - $6.00			4,710,674			$	6.00				4.5			$	-				4,141,928			$	6.00				4.5			$	-
			4,710,674			$	6.00				4.5			$	-				4,141,928			$	6.00				4.5			$	-

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
Company options		$	985			$	1,429			$	3,035			$	4,104
Wavelo options			427				422				1,322				1,380
Ting options			30				32				91				144
Capitalized stock based compensation			(55	)			(75	)			(171	)			(245	)
Total stock based compensation expense		$	1,387			$	1,808			$	4,277			$	5,383

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration